These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38036719)

  • 61. KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma.
    Pan KH; Yao L; Chen Z; Sun J; Jia Z; Zhang J; Ling Z
    Eur J Med Res; 2023 Sep; 28(1):356. PubMed ID: 37726833
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma.
    Zhang W; Wang H; Wang W; Xue H; Qiao M; Song L; Wang S; Ren Z; Ma Z
    Anal Cell Pathol (Amst); 2022; 2022():4673514. PubMed ID: 36588797
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A prognostic nomogram based on competing endogenous RNA network for clear-cell renal cell carcinoma.
    Peng Y; Wu S; Xu Z; Hou D; Li N; Zhang Z; Wang L; Wang H
    Cancer Med; 2021 Aug; 10(16):5499-5512. PubMed ID: 34196116
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients.
    Shen C; Chen Z; Jiang J; Zhang Y; Xu W; Peng R; Zuo W; Jiang Q; Fan Y; Fang X; Zheng B
    Front Genet; 2022; 13():1034567. PubMed ID: 36246657
    [No Abstract]   [Full Text] [Related]  

  • 65. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma.
    Ma T; Wang X; Wang J; Liu X; Lai S; Zhang W; Meng L; Tian Z; Zhang Y
    Front Genet; 2021; 12():726369. PubMed ID: 34721523
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
    Front Immunol; 2021; 12():734646. PubMed ID: 34795663
    [TBL] [Abstract][Full Text] [Related]  

  • 67. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of exosomes-related lncRNAs in clear cell renal cell carcinoma based on Bayesian spike-and-slab lasso approach.
    Niu Y; Jia X; Wang N; Yuan M; Dong A; Yang Y; Shi X
    Funct Integr Genomics; 2023 Feb; 23(1):62. PubMed ID: 36805328
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
    Jiang W; Guo Q; Wang C; Zhu Y
    Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma.
    Zhang H; Ning Z; Wang B; Liu Y; Tao B; Zhang G; Liu H; Wang C
    Dis Markers; 2023; 2023():7219794. PubMed ID: 36741910
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1.
    Yang W; Zhang K; Li L; Xu Y; Ma K; Xie H; Zhou J; Cai L; Gong Y; Gong K
    J Exp Clin Cancer Res; 2021 Mar; 40(1):92. PubMed ID: 33691743
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma.
    Hua S; Xie Z; Zhang Y; Wu L; Shi F; Wang X; Xia S; Dong S; Jiang J
    Front Immunol; 2022; 13():869297. PubMed ID: 35936012
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma.
    Wang Q; Tang H; Luo X; Chen J; Zhang X; Li X; Li Y; Chen Y; Xu Y; Han S
    Front Immunol; 2022; 13():890150. PubMed ID: 35686121
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
    Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y
    Front Genet; 2022; 13():787884. PubMed ID: 35350243
    [No Abstract]   [Full Text] [Related]  

  • 77. Novel immune-related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Jun; 36(6):e24409. PubMed ID: 35441741
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Survival Prognosis, Tumor Immune Landscape, and Immune Responses of ADAMTS14 in Clear Cell Renal Cell Carcinoma and Its Potential Mechanisms.
    Chen Y; Ji H; Liu S; Xing Q; Zhu B; Wang Y
    Front Immunol; 2022; 13():790608. PubMed ID: 35572505
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments.
    Wang T; Jian W; Xue W; Meng Y; Xia Z; Li Q; Xu S; Dong Y; Mao A; Zhang C
    Front Immunol; 2022; 13():1080403. PubMed ID: 36591240
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.
    Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S
    Front Immunol; 2022; 13():918154. PubMed ID: 35880180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.